Wegovy, Novo Nordisk and Weight Loss

Weight Loss Drug Will Be Offered for $499 a Month for Some Patients
Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.
Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight-loss drug Wegovy.
Novo to Sell Weight-Loss Drug Wegovy Directly to Patients
Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US patients at a discount.
There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers
Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.
These discounted versions of popular weight-loss drugs are going away: What to know
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.
Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket
Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients paying out of pocket. The deal is available through the drugmaker's new NovoCare Pharmacy offering.
Popular weight-loss drugs get cheaper: Novo Nordisk and Eli Lilly cut prices
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of $499 takes effect immediately.
Weight-loss drug battle: Who are the latest players involved
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly diving into the opportunity to make anti-obesity products. This article looks into key players in the arena.
Minnesota mulls insurance mandate for weight-loss drugs
Minnesota lawmakers are renewing a push to require insurance coverage of anti-obesity drugs like Ozempic and Wegovy. Why it matters: These life-changing drugs, known as GLP-1s, are helping millions of Americans shed pounds and lower their risk of more serious conditions like heart attacks and strokes.
Weight loss drug Wegovy will soon see price cuts
Novo Nordisk said it would drop prices by 25 percent for all doses of the drug, making the new monthly price about $500.
You’ve Already Paid for Overpriced Weight-Loss Drugs
US taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, according to new data shared with the Lever. Yet Americans are now paying pharmaceutical giants — including one in Denmark — up to eleven times more for these medicines than patients in other countries,
New Discovery Promises Weight Loss Without Ozempic's Side Effects
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...
Ozempic vs Metformin For Weight Loss: Weighing the Pros & Cons of Each
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
Specialist in Denver says popular weight loss meds impact eating disorder treatments
The medical director of a Denver eating disorder clinic says popular medications that are being used as weight loss drugs are ...
Patients struggle with lack of consistent coverage for popular weight-loss drugs
Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t ...